Stock & Company Details
Editas Medicine Inc $EDIT
Price:
N/A
N/A
154M
$453M
52 Week High:
N/A
10 Day Average Volume:
N/A
-3.94
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
EDIT technical indicators
Latest Editas Medicine Inc (EDIT) indicator readings as of 2026-10-29.
EDIT's 14-day RSI is 59.6, in neutral territory. At $2.93 it is trading 9.4% above its 200-day moving average of $2.68, and above its 50-day average of $2.77. Price sits near the upper Bollinger Band ($2.20 to $3.02). ADX reads 16.7, indicating a range-bound market rather than a trend.
Overview
Editas Medicine Inc is a genome editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
Finance Bot
Ask your questions
Start by typing a question below.
